Slow Bull
The market, slowly. SATURDAY, 26 SEPTEMBER 2026

Instil Bio, Inc.

TIL Nasdaq SEC CIK 1789769
Follow Instil Bio Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income −$4.3M +79.9% vs same quarter last year
EPS, diluted −$0.63 +80.6% vs same quarter last year
Operating cash flow −$4.6M +68.6% vs same quarter last year
Operating income −$5.6M +76.2% vs same quarter last year
Net income by quarter
−$23M
−$11.9M
−$28.2M
−$21.4M
−$13.6M
−$8.2M
−$4.2M
−$4.3M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
−$300M−$200M−$100M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$71.4M
FY24−$74.1M
FY23−$156.1M
FY22−$223.2M
FY21−$156.8M
FY20−$37.7M
FY19-
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$55.7M
FY23−$102.7M
FY22−$264.8M
FY21−$180M
FY20−$80.4M
FY19-

News

No stories filed under Instil Bio yet - coverage appears here as the news feed clusters it.